Delivery Order 36E79724D0005-36C24524N0351
Award Date 3/21/24
Potential Completion Date 10/15/24
Potential Value $47K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Durham, NC 27701, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 awarded a firm-fixed-price delivery order contract to Glaxosmithkline, LLC, a pharmaceutical company, for the provision of flu vaccines. The contract has a potential value of $80,319.00 and a completion date of October 15, 2024. The contract is not set aside for any specific business type. Glaxosmithkline has provided a range of pharmaceutical products, including vaccines, antiviral...
- The Department of Veterans Affairs Veterans Health Administration has awarded a $7,836 firm fixed price delivery order contract to Glaxosmithkline, LLC for the provision of flu vaccine. The contract has no set-aside designation and is expected to be completed by October 15, 2024. Glaxosmithkline is a pharmaceutical company that provides a range of vaccines, antivirals, and other medical products to U.S. government agencies through federal contract awards, including influenza, hepatitis, and...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 awarded Glaxosmithkline, LLC, doing business as Glaxosmithkline, a $100,776.00 firm fixed-price delivery order for flu vaccines. The contract has no set-aside designation and the period of performance runs through October 15, 2019. Glaxosmithkline is a pharmaceutical company that provides vaccines, antiviral medications, and other products to various U.S. government agencies through federal...
- This is a federal contract award from the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Glaxosmithkline, LLC, a pharmaceutical company, for the delivery of flu vaccines. The $319,475 firm fixed-price delivery order contract has an October 15, 2017 completion date and was awarded on March 30, 2017. The contract did not have a set-aside designation. Glaxosmithkline has provided a range of pharmaceutical products to U.S. government agencies through federal contracts...
- This federal contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Glaxosmithkline, LLC, a pharmaceutical company that provides vaccines, antiviral medications, and other pharmaceutical products to U.S. government agencies. The contract is for the delivery of flu vaccine, with a potential value of $266,760.00 and a completion date of January 9, 2020. The contract is a firm fixed price Delivery Order with no set-aside designation. Glaxosmithkline has...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22 awarded a firm fixed price delivery order contract to Glaxosmithkline, LLC to provide flu vaccines. The $235,697.28 contract has a completion date of May 8, 2020 and did not use a set-aside designation. Glaxosmithkline is a pharmaceutical company that provides a range of vaccines, antivirals, and other products to U.S. government agencies through federal contracts and grants. This award...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 6 awarded a firm fixed price delivery order to Glaxosmithkline, LLC, doing business as Glaxosmithkline, for the provision of FLUARIX influenza vaccine. The $58,770 contract has a performance period ending on October 15, 2024 and does not have a set-aside designation. Glaxosmithkline is a pharmaceutical company that provides a range of vaccines, antiviral medications, and other products to U.S....
- The Department of Veterans Affairs (VA) awarded Glaxosmithkline, LLC, a $124,080.00 firm fixed price delivery order contract for FLUARIX QUADRIVALENT influenza vaccines. The contract has a completion date of September 30, 2020 and does not have a set-aside designation. Glaxosmithkline is a pharmaceutical company that provides vaccines, antivirals, and other products to various U.S. government agencies. This award is associated with the VA's National Acquisition Center indefinite delivery...
- This federal contract was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to Glaxosmithkline, LLC for the delivery of flu vaccines to the VA Baltimore Medical Center for the 2024-25 flu season. The $43,000.05 firm fixed price delivery order does not have a set-aside designation. Glaxosmithkline is a global pharmaceutical company that provides a range of vaccines, antiviral medications, and other products to U.S. government agencies through various federal...
- This is a $44,077.50 firm fixed price delivery order awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Glaxosmithkline, LLC to provide flu shots. The contract has no set-aside designation and the period of performance runs through October 31, 2024. Glaxosmithkline, a foreign-owned pharmaceutical company, has held multiple federal contracts and grants to supply vaccines, antivirals, and other pharmaceutical products to government agencies like the...
Teaming
Find teaming partners for this award
- 36E79724D0005Indefinite Delivery Contract
- 36E79724D0005-36C24524N0351Delivery Order
The Department of Veterans Affairs Veterans Health Administration awarded Glaxosmithkline, LLC, a pharmaceutical company, a $47,016.00 firm fixed price delivery order contract to provide influenza vaccines for the Martinsburg VA Medical Center. The contract has an October 15, 2024 completion date and does not have a set-aside designation. Glaxosmithkline has provided a range of pharmaceutical products and services to U.S. government agencies, including vaccines, antiviral medications, and COVID-19 treatments. The company holds several federal contract vehicles for pharmaceutical and vaccine supply, including a $15 million contract with the VA National Acquisition Center to provide seasonal influenza vaccines.
Generated 3/22/24, 11:03 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $47.0k | 3/21/24 |